Introduction {#s1}
============

Epidemiologically, there are well-established gender differences in the manifestations of cardiac arrhythmias. Men are more susceptible to the development of atrial fibrillation (AF) [@pone.0054635-Kannel1], [@pone.0054635-Wolbrette1], whereas women have higher incidence of long-QT syndrome (LQTS) and drug-induced Torsades de Pointes [@pone.0054635-Locati1], [@pone.0054635-AbiGerges1]. In addition, men and women exhibit differences in basic electrophysiological parameters during normal sinus rhythm. Women, for example, tend to have increased resting heart rates [@pone.0054635-Burke1] and longer rate-corrected QT (QTc) intervals [@pone.0054635-Kligfield1], whereas men have been reported to have longer P-waves suggesting differences in baseline atrial electrophysiological properties [@pone.0054635-Dhala1]. Interestingly, autonomic blockade does not mask the gender differences in resting heart rate, suggesting that intrinsic sinus node differences, as opposed to gender dependent autonomic tone, are responsible for this variability [@pone.0054635-Burke1].

Much less is known, however, about the molecular mechanisms underlying observed gender differences in arrhythmia susceptibility and basic electrophysiological parameters in the human heart. Insight has been gained primarily from animal models, particularly studies in the rabbit, dog, and mouse [@pone.0054635-James1]. The rabbit heart has been suggested to be a relevant model for the study of human arrhythmias [@pone.0054635-Panfilov1] and female rabbits also exhibit gender dependent differences in QTc intervals [@pone.0054635-Ebert1] similar to that seen in humans [@pone.0054635-Kligfield1]. Although mice afford easy genetic manipulations, they manifest profound differences in cardiac electrophysiology compared to humans [@pone.0054635-Nerbonne1], [@pone.0054635-AhrensNicklas1] which must be considered when extending conclusions to human physiology and pathophysiology [@pone.0054635-Glukhov1], [@pone.0054635-Fedorov1]. Since the expression profile of ion channels and transporters determine cardiac excitability and may also determine arrhythmia susceptibility, several recent studies have explored gene expression patterns in the human heart [@pone.0054635-Borlak1], [@pone.0054635-Gaborit1], [@pone.0054635-Chandler1], [@pone.0054635-Nattel1], [@pone.0054635-Gaborit2], [@pone.0054635-Gronich1]. As the ever present limitation to detailed human studies is the availability of human tissues for analysis, we have developed the infrastructure necessary to collect and systematically investigate tissues from both failing and nonfailing human hearts suitable for detailed functional and molecular analyses. In addition to investigating the global patterns of mRNA expression relating to gender and heart failure in the human heart, we have also provided a comprehensive set of data which was used to computationally model patient-specific electrophysiology and explore population-dependent variability in action potential morphology by our colleagues Walmsley, et al.

We focused on probing tissues of the left atria (LA) and ventricle (LV), as left-sided heart remodeling and dysfunction are the most common manifestations of heart failure [@pone.0054635-McKee1], [@pone.0054635-Hunt1]. Specifically, we quantified the transcript expression levels of 89 target genes in the LA and LV of failing and nonfailing human hearts of both genders. In some analyses, tissues isolated from the epicardium and endocardium of the LV were examined separately as we have previously shown that heart failure results in a heterogeneous remodeling of repolarization across the ventricular wall and altered dispersion [@pone.0054635-Glukhov2], which may be pro-arrhythmic [@pone.0054635-Antzelevitch1].

Methods {#s2}
=======

The use of human hearts for research was approved by the Institutional Review Board at Washington University in St. Louis.

Human Tissue Samples {#s2a}
--------------------

For this study a total of 34 explanted human hearts of both genders (n = 16 women, 52±10 years old; n = 18 men, 52±14 years old) were acquired from two sources ([Figure 1](#pone-0054635-g001){ref-type="fig"}). Failing human hearts (n = 16; 9 men, 7 women) were obtained at the time of cardiac transplantation at Barnes-Jewish Hospital (St. Louis, MO) and nonfailing hearts (n = 18; 9 men, 9 women) were provided by Mid-America Transplant Services (St. Louis, MO) after they were deemed unsuitable for cardiac transplantation. Each heart was collected in the operating room after removal from the chest and immediately perfused with and stored in cardioplegic solution (4°C) for preservation during the 15--20 minute delivery from the operating room to the research laboratory. Upon arrival, tissue samples from the LA (n = 22) and LV (n = 22) free walls were immediately harvested and preserved. Epicardial and endocardial samples were also harvested from the LV free wall (n = 12). All tissue samples were preserved and stored in RNAlater (Sigma-Aldrich, St. Louis, MO) at −80°C. Basic clinical characteristics of the patients are shown in [Tables 1](#pone-0054635-t001){ref-type="table"} and [2](#pone-0054635-t002){ref-type="table"}.

![Study population (n = 34).](pone.0054635.g001){#pone-0054635-g001}

10.1371/journal.pone.0054635.t001

###### Clinical characteristics of nonfailing hearts.

![](pone.0054635.t001){#pone-0054635-t001-1}

  HeartNumber    Gender   Age     Cause of Death      LVEDD[\*](#nt101){ref-type="table-fn"} (cm)   EF[†](#nt102){ref-type="table-fn"} (%)
  ------------- -------- ----- --------------------- --------------------------------------------- ----------------------------------------
  1              Female   55          Stroke                            unknown                                      \<20
  2              Female   33        Head Trauma                         unknown                                    unknown
  3              Female   59    Anoxic Brain Injury                     unknown                                    unknown
  4              Female   66          Stroke                            unknown                                    unknown
  5              Female   34        Brain Death                           4.8                                         20
  6              Female   58          Stroke                            unknown                                       30
  7              Female   49          Anoxia                              4.1                                         65
  8              Female   59          unknown                           unknown                                    unknown
  9              Female   50          Anoxia                            unknown                                     60--65
  10              Male    19          Anoxia                              4.1                                         45
  11              Male    60        Head Trauma                           3.3                                         65
  12              Male    55          Stroke                              4.7                                         35
  13              Male    50          Stroke                            unknown                                    unknown
  14              Male    52        Head Trauma                           4.3                                       60--70
  15              Male    65          Stroke                            unknown                                    unknown
  16              Male    58          Stroke                            unknown                                     60--70
  17              Male    20       Drug Overdose                        unknown                                    unknown
  18              Male    59        Brain Death                         unknown                                    unknown
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10.1371/journal.pone.0054635.t002

###### Clinical characteristics of failing hearts.

![](pone.0054635.t002){#pone-0054635-t002-2}

  Heart Number    Gender   Age                Diagnosis                                                    Devices                                      LVEDD[\*](#nt103){ref-type="table-fn"} (cm)   EF[†](#nt105){ref-type="table-fn"} (%)                                Arrhythmia History
  -------------- -------- ----- -------------------------------------- ------------------------------------------------------------------------------- --------------------------------------------- ---------------------------------------- ------------------------------------------------------------------------------
  1               Female   65    ICM[‡](#nt107){ref-type="table-fn"}                         ICD[§](#nt109){ref-type="table-fn"}                                            6.4                                         15                     NSVT[\|\|](#nt111){ref-type="table-fn"}, VF[\#](#nt113){ref-type="table-fn"}
  2               Female   49                    ICM                                                         ICD                                                            5.9                                       25--30                                      VT[\*\*](#nt104){ref-type="table-fn"}
  3               Female   53                    ICM                                                         ICD                                                            6.5                                         20                                                    No arrhythmias
  4               Female   67                    ICM                                                         ICD                                                             7                                          10                                                    No arrhythmias
  5                Male    50                    ICM                    PPM[a](#nt106){ref-type="table-fn"}, ICD, BiV[b](#nt108){ref-type="table-fn"}                        7                                         \<15                                                   Refractory VT
  6                Male    44                    ICM                                      ICD, LVAD[c](#nt110){ref-type="table-fn"}                                          7                                         \<15                                                   No arrhythmias
  7                Male    69                    ICM                                                    PPM, ICD, BiV                                                      7.13                                         39                                        AF[d](#nt112){ref-type="table-fn"}, VT
  8                Male    63                    ICM                                                    PPM, ICD, BiV                                                       7.6                                         15                                                    No arrhythmias
  9                Male    50                    ICM                                                         ICD                                                            6.6                                         30                                                       NSVT, VF
  10               Male    67                    ICM                                                      ICD, LVAD                                                         7.9                                         10                                                    No arrhythmias
  11              Female   44    NICM[e](#nt114){ref-type="table-fn"}                                     ICD, LVAD                                                         5.5                                       20--25                                                        AF
  12              Female   54                    NICM                                                        ICD                                                            6.1                                        \<20                                                       AF, VT
  13              Female   46                    NICM                                                     ICD, LVAD                                                         7.8                                         16                                                          AF
  14               Male    70                    NICM                                                        ICD                                                           \>6.6                                        16                                                          AF
  15               Male    47                    NICM                                                       LVAD                                                            6.4                                         25                                                          VT
  16               Male    53                    NICM                                                        ICD                                                            8.2                                         16                                                          VT
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RNA Extraction and Preparation {#s2b}
------------------------------

Total RNA was extracted from 68 samples using the RNEasy Fibrous Tissue Mini Kit (Qiagen, Valencia, CA) according to the manufacturer's instructions. RNA yield was measured using a Nanodrop 1000 (Thermo Scientific) and quality was assessed by verifying the presence of the 18 S and 28 S bands as run on a 1% agarose gel.

Low-Density Taqman Gene Arrays {#s2c}
------------------------------

Custom-designed low-density Taqman gene arrays (Applied Biosytems, Foster City, CA) were used to probe for the presence of 96 targets in a two-step process as described previously [@pone.0054635-Gaborit1], [@pone.0054635-Gaborit2], [@pone.0054635-Marionneau1]. In short, total RNA (1--2 µg) was first converted to cDNA using the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA). Subsequent reactions were performed, using 100 ng of cDNA loaded into each well of our custom-designed gene arrays, with the ABI PRISM 7900 HT Sequence Detection System (Applied Biosystems, Foster City, CA). Genes selected for analysis included 56 ion channels and accessory proteins, 14 calcium-handling proteins, 9 autonomic receptors, 6 transcription factors, 3 signaling proteins, and 8 controls/marker genes and are listed in [Table S1](#pone.0054635.s002){ref-type="supplementary-material"}.

Statistics and Data Analysis {#s2d}
----------------------------

Data were collected and analyzed by the Applied Biosystems SDS 2.3 software using the threshold cycle (C~t~) relative quantification method [@pone.0054635-Livak1] with GAPDH as an endogenous control. Quantitative data are expressed as mean ± standard deviation. Statistically significant differences were identified using a one-way analysis of variance followed by Tukey-Kramer's test with a significance level of p\<5.6×10^−4^ based on the Bonferroni correction (GenEx; MultiD, Santa Clara, CA). All quantitative results are available at the NIH GEO database (GEO Accession \#GSE33165).

In addition, two-way hierarchical agglomerative cluster analysis was performed using the ΔΔC~t~ of each target. We applied average linkage clustering with calculation of Euclidean distances. Clusters were analyzed and visualized using Cluster 3.0 and Treeview software [@pone.0054635-Eisen1].

Results {#s3}
=======

Hierarchical Cluster Analysis {#s3a}
-----------------------------

Hierarchical cluster analysis was used to determine if strong enough overall trends in transcript expression across gender, disease, and cardiac chambers manifested to create distinct clusters of highly-related samples. As is shown in the Online Data Supplement ([Figure S1](#pone.0054635.s001){ref-type="supplementary-material"}), LA and LV samples from ischemic and nonfailing hearts of both genders show distinct clustering based on chamber location ([Figure S1A](#pone.0054635.s001){ref-type="supplementary-material"}). These samples do not cluster, however, based on gender or disease state. We also explored cluster analysis of ischemic, nonischemic, and nonfailing LV samples of both genders ([Figure S1B](#pone.0054635.s001){ref-type="supplementary-material"}), as well as nonischemic and nonfailing samples from the epicardium and endocardium of the LV ([Figure S1C](#pone.0054635.s001){ref-type="supplementary-material"}). Clustering of these latter samples based on gender, disease, or cardiac location was not evident.

Ventricular Remodeling in Heart Failure and Differences in Transcript Expression {#s3b}
--------------------------------------------------------------------------------

Previous studies have revealed that during the heart failure remodeling process, the cardiac action potential is significantly prolonged and conduction is slowed due to pathological changes in the expression and function of ion channels [@pone.0054635-Janse1], [@pone.0054635-Aiba1]. As shown in [Figure 2A](#pone-0054635-g002){ref-type="fig"}, we observe trends for reduction in the expression of transcripts encoding ion channel subunits that are important in cardiac conduction and repolarization, as well as changes in key calcium handling proteins. Similar to previously reported findings, for example, we observe downregulation of the subunits encoding for I~KATP~ [@pone.0054635-Flagg1] and I~to~ [@pone.0054635-Kaab1]. I~to,fast~ channels, in particular, encoded by the pore-forming subunit K~v~4.3 and the accessory protein KChIP2, is one of the most consistently altered ion channels during the heart failure remodeling process across species [@pone.0054635-Zicha1]. Consistent with previous suggestions, reductions in I~to,fast~ density in the failing heart are linked to protein-level downregulation of K~v~4.3 and transcript-level downregulation of KChIP2 [@pone.0054635-Soltysinska1]. We find lower KChIP2 expression in LV samples from failing, compared with nonfailing hearts ([Figure 2A](#pone-0054635-g002){ref-type="fig"}). In contrast with the findings for KChIP2, we observe no significant changes in the expression of subunits encoding I~K1~, I~Na~, and I~Ca,L~ channels. There is, however, a trend for lower expression of K~v~11.1/HERG, the subunit encoding the rapid component of delayed rectification, I~Kr~, as well as the calcium handling proteins, SERCA2a and NCX1, consistent with recent findings [@pone.0054635-Soltysinska1]. Finally, we observe a downregulation of connexin 43 in nonischemic, but not ischemic, cardiomyopathy.

![Ventricular remodeling in heart failure.\
(A) Ventricular remodeling of major ion channel subunits and accessory proteins in heart failure. (B) Regional specificity of targets in failing and nonfailing hearts of both genders.](pone.0054635.g002){#pone-0054635-g002}

Major differences in atrial-ventricular transcript expression patterns are shown in [Figure 2B](#pone-0054635-g002){ref-type="fig"}. Consistent with previous findings, we observed atrial predominance of several transcripts, such as connexin 40, TASK-1, TWIK-1, K~ir~2.1, K~v~1.5, K~ir~3.1, Ca~v~3.1, and sarcolipin [@pone.0054635-Nattel1], [@pone.0054635-Ellinghaus1], [@pone.0054635-Shanmugam1]. In addition, with the exception of connexin 40, we measured similar expression levels of the connexin 40, 45, and 43 transcript in both the LA and LV ([Figure 2B](#pone-0054635-g002){ref-type="fig"}).

The general agreement of our findings, regarding both ventricular remodeling during heart failure and atrio-ventricular specificity, with previous studies [@pone.0054635-Nattel1], [@pone.0054635-Flagg1], [@pone.0054635-Kaab1], [@pone.0054635-Ellinghaus1], [@pone.0054635-Shanmugam1] both supports the validity of our findings and allows for the exploration of other novel gene expression patterns with regard to gender and arrhythmia susceptibility.

Gender Dependent Atrial/Ventricular Bias {#s3c}
----------------------------------------

A gender-based comparison of overall relative expression levels for all targets in both failing and nonfailing hearts is shown in [Figure 3](#pone-0054635-g003){ref-type="fig"}. As is evident in [Figure 3B](#pone-0054635-g003){ref-type="fig"}, there is a distinct atrial gender bias, with males exhibiting overall higher expression levels of almost all transcripts quantified as compared with females. In the ventricles, there is also a slight male bias in overall relative transcript expression levels ([Figure 3C](#pone-0054635-g003){ref-type="fig"}), although in contrast with the atria the pattern emerges in nonfailing hearts, as opposed to failing LV. Interestingly, previous studies in wild-type mouse hearts demonstrated a similar male gender bias in overall atrial gene expression [@pone.0054635-Iacobas1].

![Gender dependent comparison of relative expression levels of all genes.\
(A) Nonfailing male versus female LA. (B) Failing male versus female LA showing a distinct male bias. (C) Nonfailing male versus female LV. (D) Failing female versus male LV. The dotted diagonal line represents equal expression levels between genders.](pone.0054635.g003){#pone-0054635-g003}

Gender Dependent Atrial Remodeling {#s3d}
----------------------------------

Because epidemiological data have revealed that males have an increased overall lifetime risk of developing atrial fibrillation [@pone.0054635-Kannel1], [@pone.0054635-Wolbrette1], we compared the expression levels of the major ion transcripts that have been shown or are postulated to undergo pathological remodeling [@pone.0054635-VanWagoner1], [@pone.0054635-Gaborit3], [@pone.0054635-Workman1]. The gender dependent relative expression levels of these transcripts are shown in [Figure 4A](#pone-0054635-g004){ref-type="fig"}.

![Gender dependent remodeling in the LA.\
(A) Gender dependent atrial remodeling of major ion channel subunits and accessory proteins in failing and nonfailing hearts of both genders. (B) Relative expression levels of failing LA samples of both genders. The white data points indicate the patient with a documented history of AF.](pone.0054635.g004){#pone-0054635-g004}

Atrial fibrillation has been shown to be associated with significant reductions in I~to~ [@pone.0054635-VanWagoner2], I~Kur~ [@pone.0054635-Brandt1], I~KACh~ [@pone.0054635-Dobrev1], and I~Ca,L~ [@pone.0054635-Yue1], [@pone.0054635-VanWagoner3], whereas I~K1~ current tends to be increased in AF patients [@pone.0054635-Dobrev1] and I~Na~ has been shown to not be significantly altered [@pone.0054635-Bosch1]. Surprisingly, when we assessed the gender dependence of these targets in our overall patient population, we observe patterns consistent with our female population being potentially more susceptible to the development of atrial fibrillation. As seen in [Figure 4A](#pone-0054635-g004){ref-type="fig"}, our female subjects exhibit lower expression levels in atrial K~v~4.3, KChIP2, K~v~1.5, and K~ir~3.1, as compared with our male subjects. We also see trends for lower expression in Na~v~1.5 and Ca~v~1.2, with no significant changes or trends in K~ir~2.1.

Based on the known clinical characteristics of our patient population, we identified one failing human heart (\#7) with a documented history of AF from which we analyzed an LA specimen. Contrary to our expectations, as shown in [Figure 4B](#pone-0054635-g004){ref-type="fig"}, this particular sample had the highest relative expression levels of K~v~4.3, KChIP2, K~ir~2.1, Na~v~1.5, and K~v~1.5 when compared to all failing LA specimens of both genders. This samples does, however, have a lower relative expression level of Ca~v~1.2 than other male specimens in this group.

We also explored the gender dependence of relative expression levels for adrenergic receptors, as an increased level of adrenergic activity can be associated with the onset of AF [@pone.0054635-Workman2]. As seen in [Figure 5A](#pone-0054635-g005){ref-type="fig"}, we do not observe any significant differences in adrenergic receptor expression in the LA of failing and nonfailing hearts. There is an apparent trend that males tend to exhibit overall higher relative expression levels of α1b, α1d, β1, and β2 adrenergic receptors. This finding, however, may be due to an intrinsically decreased sympathetic tone in women as compared to men [@pone.0054635-Ramaekers1]. Interestingly, as shown in [Figure 5B](#pone-0054635-g005){ref-type="fig"}, the failing heart (\#7) with a history of AF displays the highest relative expression levels of all of the adrenergic receptors analyzed.

![Gender dependent remodeling of adrenergic receptors.\
(A) Gender dependent atrial remodeling of adrenergic receptors in failing and nonfailing hearts of both genders. (B) Relative expression levels of adrenergic receptors in failing LA samples of both genders. The white data points indicate the patient with a documented history of AF.](pone.0054635.g005){#pone-0054635-g005}

Gender Dependent Ventricular Remodeling {#s3e}
---------------------------------------

Epidemiologically, females tend have a higher incidence of LQTS and drug-induced Torsades de Pointes [@pone.0054635-Locati1], [@pone.0054635-AbiGerges1]. Subsequent analysis therefore focused on a subset of ion channels known to be important in cardiac repolarization [@pone.0054635-James1], [@pone.0054635-Nerbonne2]. As shown in [Figure 6](#pone-0054635-g006){ref-type="fig"}, quantification of the relative expression levels of these transcripts revealed no significant differences in patterns based on gender. In addition, direct comparison of the expression levels of these transcripts linked to repolarization in LV samples from failing hearts with and without histories of ventricular tachyarrhythmias also do not reveal any striking patterns as shown in [Figure 7](#pone-0054635-g007){ref-type="fig"}.

![Gender dependent ventricular remodeling of major repolarizing ion channel subunits and accessory proteins in failing and nonfailing hearts of both genders.](pone.0054635.g006){#pone-0054635-g006}

![Relative expression levels of failing LV samples of both genders.\
The white data points indicate patients with a documented history of ventricular tachyarrhythmias.](pone.0054635.g007){#pone-0054635-g007}

Gender Dependent Transmural Heterogeneity {#s3f}
-----------------------------------------

Transmural heterogeneities in action potential waveforms across the ventricular wall are major determinants of arrhythmia susceptibility [@pone.0054635-Antzelevitch2] and directly alter electrophysiological parameters during heart failure [@pone.0054635-Glukhov2] [Figure 8](#pone-0054635-g008){ref-type="fig"} shows the ratios of epicardial to endocardial expression for key transcripts linked to repolarization in failing and nonfailing hearts of both genders. Ratios of around one indicate those transcripts, such as K~v~7.1/K~v~LQT1, mink, K~ir~2.1, K~ir~2.2, K~ir~2.3, K~v~4.3, and Ca~v~1.2, that are uniformly expressed across the transmural wall of the LV in both failing and nonfailing hearts. On the other hand, ratios of either greater or less than one represent transcripts that are more heterogeneously expressed across the LV transmural wall. For example, KChIP2, the accessory protein for I~to~ channels, exhibits a significantly larger ratio than any of the other targets shown in [Figure 8](#pone-0054635-g008){ref-type="fig"}. In the failing male heart, however, this heterogeneity is not present as the ratio of epicardial to endocardial expression is one. Kv1.4, a pore-forming subunit for I~to,slow~, displays a reduced ratio in nonfailing hearts, but again, as with KChIP2, the transmural expression ratio is one in the failing heart.

![Average ratios of epicardial to endocardial expression of repolarization targets in failing and nonfailing hearts of both genders.\
The dotted back line represents a ratio of one.](pone.0054635.g008){#pone-0054635-g008}

Discussion {#s4}
==========

In the present study, we explored the impact of gender on the transcript expression levels of the major cardiac ion channels, calcium handling proteins, and transcription factors in the failing and nonfailing human heart. We found gender-specific differences in relative expression levels of ion channel subunits, such as K~v~4.3, KChIP2, K~v~1.5, and K~ir~3.1 in the LA, but no significant gender-specific differences in relative expression levels of these subunits in the LV. Analyses of transmural heterogeneities in transcript expression levels in the LV, however, revealed a heterogeneity of expression across the LV wall in of the I~to,slow~ pore-forming subunit, K~v~1.4, as well as with the I~to,fast~ accessory subunit, KChIP2. In the nonfailing heart, K~v~1.4 exhibited higher expression in the epicardium of the nonfailing heart, whereas KChIP2 exhibited a stronger expression in the epicardium across gender and disease state.

Until recently, there has been very limited data available regarding global gender dependent cardiac ion channel gene expression in the human heart. A 2010 study by Gaborit, et al [@pone.0054635-Nattel1] explored gender dependent differences in the nonfailing human ventricle (left and right ventricles) and, unlike in our investigation, found significantly lower expression levels in the female LV of key ion channels and accessory proteins important in cardiac repolarization. Their patient population consisted of 10 men and 10 women with average ages of 38±12 years and 43±13 years, respectively. Our patient population, on the other hand, consisted of both failing and nonfailing human hearts with significantly older average ages (failing females, 54±9 years; failing males, 56±9 years; nonfailing females, 51±11 years, failing males, 50±18 years). The variability of qPCR data has shown to be significantly increased in aged animals [@pone.0054635-Tellez1] and humans [@pone.0054635-Boheler1], which in our case may mask any intrinsic gender dependent expression differences in the LV in our study.

The use of an older patient population may, however, be more representative with respect to the gender dependent analysis of LA targets important in the generation and maintenance of AF, as AF is relatively uncommon before the age of 60 and 10% of the overall population develops AF by 80 years of age [@pone.0054635-Go1]. In addition, 1 in 4 heart failure patients develop AF within five years of diagnosis [@pone.0054635-Wang1], so it is likely that relevant atrial remodeling processes [@pone.0054635-Nattel2] are well underway in our patient population. Interestingly, although overall men are more likely to develop heart failure [@pone.0054635-Bui1], women diagnosed with heart failure are approximately 1.5 times more likely to develop AF than their male counterparts [@pone.0054635-Benjamin1]. Additionally, the overall higher atrial expression levels of almost all transcripts analyzed in this study ([Figure 3B](#pone-0054635-g003){ref-type="fig"}) in the failing male hearts, as compared to failing female hearts, may mask any intrinsic gender-based differences.

Interpretation of these results, however, with respect to both the LA and LV must be considered in light of the available clinical information, as shown in [Tables 1](#pone-0054635-t001){ref-type="table"} and [2](#pone-0054635-t002){ref-type="table"}. As described in the Results section, we identified one patient (failing heart no. 7) with a history of AF. This patient exhibited high expression levels of K~v~4.3, KChIP2, K~ir~2.1, Na~v~1.5, and K~v~1.5 when compared with all other failing LA specimens of both genders, as shown in [Figure 4B](#pone-0054635-g004){ref-type="fig"}. This sample did, however display a relatively lower expression level of Ca~v~1.2 as compared with other specimens in the group, which is likely related to the patient's four-month history of permanent AF prior to transplantation. It should also be noted that, prior to diagnosis of AF, this patient had been previously diagnosed with ventricular arrhythmias which concurrently played a role in the progression of heart failure and overall arrhythmia history. As previously reported, in human AF the primarily physiological remodeling results from changes in I~Ca,L~ and significant reductions of current density have only been reported after 18 months of persistent AF [@pone.0054635-Brundel1]. In addition, as shown in [Figure 7](#pone-0054635-g007){ref-type="fig"}, we observed no remarkable expression patterns in key repolarization targets in the LV of failing hearts with and without a history of ventricular tachyarrhythmias, which may in part be due to the individual etiologies of heart failure, which must be elucidated further in future studies.

Prolongation of the cardiac action potential is a hallmark of heart failure [@pone.0054635-Tomaselli1]. Furthermore, heterogeneous distribution of repolarization transmurally across the ventricular wall manifests as electrophysiological heterogeneities which may also be pro-arrhythmic [@pone.0054635-Antzelevitch2]. In our recent study, we provide direct experimental evidence of transmural heterogeneites in action potential waveforms in the human LV wedge preparation [@pone.0054635-Glukhov2]. In the present study, as shown in [Figure 8](#pone-0054635-g008){ref-type="fig"}, we explored the potential molecular mechanisms of this functional heterogeneity. The data reveal expression gradients in KChIP2 expression across the transmural wall consistent with differences in I~to~ [@pone.0054635-Antzelevitch2]. We were unable, however, to pinpoint other channels potentially contributing to action potential heterogeneity as the transcripts encoding the other ion channels prominent in repolarization were found to be more homogenously expressed across the LV wall. In addition, we did not find connexin 43 transcript expression to be heterogeneously expressed, although previous reports have demonstrated significantly lower epicardial connexin 43 protein expression in both failing and nonfailing hearts in our previous study [@pone.0054635-Glukhov2]. Patterns of molecular heterogeneity directly affecting action potential durations may either be due to the presence of smaller "islands" of differential gene expression and function [@pone.0054635-Glukhov2], [@pone.0054635-Antzelevitch3] not captured in this study or post-translational protein modifications [@pone.0054635-Roden1] not assessed in our transcript level investigation.

The wealth of information gathered from large-scale gene expression studies such as this and others [@pone.0054635-Chandler1], [@pone.0054635-Gaborit2], not only provides insight into the gender dependent, pathological, or regional changes in ion channel expression, but also provides solid physiological data that can be incorporated into computational models. Furthermore, access to detailed clinical information, such as that presented this study, will both assist in interpretation of the molecular mechanisms involved in heart failure and arrhythmogenesis, as well as contribute to the development of tools for patient-specific computational models of cardiac electrophysiology. Constructing models of comprehensive human electromechanical activity requires a thorough understanding of the distribution of ion channels, calcium handling proteins, and other transporters in various regions of the heart, as well as their intrinsic modifications due to disease and gender as we have investigated in this study. Our colleagues Walmsley, et al in their paper "mRNA expression levels in failing human hearts predict cellular electrophysiological remodeling using a population-based simulation study" in this issue of the journal, present a first step towards patient-specific modeling of the action potential and calcium transient based on the comprehensive set of molecular data presented here.

Study Limitations {#s4a}
-----------------

The study of human hearts, while providing a unique opportunity to explore both the structural and functional mechanisms pertaining to arrhythmias, heart failure, and other pathological conditions, is limited by number of explanted hearts available. Nonfailing, donor hearts are especially precious and cannot be truly considered normal, control hearts due to that fact that they have been rejected for transplantation due to, in some cases, cardiac reasons. In addition, the underlying patient circumstances (i.e. medication, previous cardiac surgery, etc) cannot be controlled for. Thus, the hearts presented in this study represent the best available specimens.

Conclusion {#s4b}
----------

Epidemiologically, it is clear there is a gender disparity in arrhythmia incidence. To attempt to elucidate the underlying molecular mechanisms of these differences, we have explored the gender dependent expression of various ion channels, calcium handling proteins, and other transcription factors in the failing and nonfailing human heart in this study. While we observed significant gender dependent differences in atrial tissues, we did not however observe clear patterns of gender dependent expression in the ventricles. Our data do, however, emphasize the importance of addressing such confounding factors as gender, age, and disease progression when exploring ionic remodeling processes in the human heart and in constructing patient-specific models of cardiac electrophysiology.

Supporting Information {#s5}
======================

###### 

**Hierarchical Cluster Analysis.** (A) Cluster analysis of ischemic and nonfailing LA/LV samples of both genders showing distinct separation based on cardiac location. (B) Cluster analysis of ischemic, nonischemic, and nonfailing LV samples showing no clustering. (C) Cluster analysis of nonischemic and nonfailing epicardial/endocardial samples also showing no clustering.

(TIF)

###### 

Click here for additional data file.

###### 

**Custom-designed Taqman low-density gene array targets.**

(DOCX)

###### 

Click here for additional data file.
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